MMP9 Recombinant Rabbit mAb (SDT-1591-27)

產(chǎn)品型號：S0B3420

更新時(shí)間：2025-06-29

廠商性質(zhì)：生產(chǎn)廠家

訪問量：54

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

斯達(dá)特HbA1c配對抗體：為糖尿病研究與臨床診斷提供原料

PD-L1 IHC抗體

IHC腫瘤標(biāo)志物 | 常見胃癌和結(jié)直腸癌診斷

p16/Ki-67雙染：子宮頸癌前病變診斷的精準(zhǔn)之道

產(chǎn)品介紹

Matrix metalloproteinase-9 （MMP-9）, also known as gelatinase B, is a 92 kDa zinc-dependent endopeptidase and a member of the matrix metalloproteinase （MMP） family. It is synthesized and secreted as an inactive zymogen, which contains an N-terminal propeptide domain, a zinc-containing catalytic domain with three fibronectin type II repeats, and a C-terminal hemopexin-like domain. MMP-9 plays a crucial role in the degradation of various extracellular matrix （ECM） components, such as collagen, fibronectin, and laminin, and is involved in tissue remodeling. It is also associated with multiple pathological processes, including cancer, chronic inflammation, and cardiovascular diseases. MMP9 has been found to be associated with numerous pathological processes, including cancer, arthritis, placental malaria, immunologic and cardiovascular diseases, and it has been explored as a potential biomarker and therapeutic target.

上一個(gè)：S0B3421MMP9 Recombinant Rabbit mAb (SDT-1591-56)